SOCIOECONOMIC DISPARITIES AND LATE ONSET GROUP B STREPTOCOCCUS IN TENNESSEE, 2010-2014 by Jones, Cassandra
  
 
Master of Public Health Field Experience Report 
 
 
 
 
SOCIOECONOMIC DISPARITIES AND LATE ONSET GROUP B 
STREPTOCOCCUS IN TENNESSEE, 2010-2014 
 
by 
 
CASSANDRA JONES 
MPH Candidate 
 
 
 
submitted in partial fulfillment of the requirements for the degree 
 
MASTER OF PUBLIC HEALTH 
 
 
 
Graduate Committee: 
Dr. Annelise Nguyen 
Dr. Anne Sally Davis 
Dr. Natalia Cernicchiaro 
 
 
 
Field Experience Site: 
Tennessee Emerging Infections Program 
May 17- July 28, 2016 
 
Field Experience Preceptors: 
William Schaffner, MD; Tim Jones, MD 
 
 
 
KANSAS STATE UNIVERSITY 
Manhattan, Kansas 
 
 
2016 
 
  
  
Copyright 
CASSANDRA JONES 
2016 
 
 
  
  
Summary 
My capstone project and field experience gave me the opportunity to increase my public 
health knowledge and skills. I spent the summer of 2016 at the Tennessee Emerging Infections 
Program at Vanderbilt University Medical Center in Nashville. Through my field experience, I 
learned how to obtain consent from patients for clinical trials, surveillance techniques, and how 
to extract pertinent health information from medical charts. I completed two projects during my 
time in Nashville. My minor project involved a random 10% audit of the 2015 Active Bacterial 
Core surveillance data and the creation of a database to house this and future audit information, 
and my primary project involved summarizing data on late onset group B Streptococcus and 
socioeconomic disparities in Tennessee from 2010-2015.  
Group B Streptococcus is the leading cause of neonatal sepsis. Since the introduction of 
the CDC’s Guidelines for the Prevention of Perinatal Group B Streptococcal Disease in 1996, the 
incidence rate of early onset disease has steadily declined. However, the incidence of late onset 
disease has remained stable. My primary project was to summarize late onset group B 
Streptococcus surveillance data for the preparation of a future, larger study. The purpose of this 
pilot was to identify areas of socioeconomic disparities for future analysis. 
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Chapter 1 - Field Experience: Tennessee Emerging Infections 
Program, Nashville, TN 
 Introduction 
In response to the increase in world travel and trade, antibiotic resistance, and the 
emergence or reemergence of infectious diseases both inside and outside of the United States, the 
Centers for Disease Control and Prevention (CDC) developed the Emerging Infections Program 
(EIP) in 1995. The CDC published its plan in the April 1994 copy of Morbidity and Mortality 
Weekly Report (MMWR): Addressing Emerging Infectious Disease Threats: A Prevention 
Strategy for the United States, Executive 
Summary (Centers for Disease Control & 
Prevention, 1994). The summary highlighted 
four goals for the program that focused on 
surveillance, research, prevention and 
control, and public health infrastructure. 
These goals are listed in Box 1.1. During its 
inception in 1995, there were four EIP sites: 
California, Connecticut, Minnesota, and 
Oregon. Since that time, six more sites have 
been established for a total of 10, as follows: 
Georgia, Maryland, New York, Tennessee, 
Colorado, and New Mexico.  Figure 1.1 
shows a history of the Emerging Infections Program.  These sites are comprised of their 
respective State Health Department and academic partners. State agencies have legal authority 
for conducting surveillance, and academic partners function as agents of the state health 
departments (Pinner et al., 2015).  
 
The Emerging Infections Program (EIP) is divided into four main program areas 
consisting of invasive bacterial diseases, foodborne diseases, health care-associated infections 
(HAI), and influenza. The Active Bacterial Core Surveillance (ABCs) program focuses on 
invasive bacterial surveillance and epidemiology.  
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Pathogens monitored by this program include, but are not limited to, Streptococcus pneumoniae, 
groups A and B Streptococcus, Haemophilus influenzae, and Neisseria meningitidis. The 
Foodborne Disease Active Surveillance Network (FoodNet) is a collaboration between the EIP, 
USDA, and the FDA and monitors pathogens such as Campylobacter, Cryptosporidium, 
Cyclospora, Salmonella spp., Shiga toxin-producing Escherichia coli, and Shigella, among 
others.  The Healthcare-Associated Infections Community Surveillance (HAIC) probes into 
major and emerging HAIs and antibiotic resistance. The Influenza Hospitalization Surveillance 
Network (Flu-Surv NET), in addition to other networks, utilizes laboratory-confirmed influenza 
hospitalization surveillance data to understand the severity and trends of seasonal flu outbreaks 
and to assess the success of yearly vaccinations. EIP also houses smaller programs such as 
TickNET and the HPV IMPACT project. The Tennessee section of TickNet is exploring novel 
agents of tickborne disease by utilizing high-throughput screening and genomic sequencing. The 
Human Papillomavirus (HPV) IMPACT project, conducted in five of the ten EIP sites, evaluates 
the post-licensure success in prevention of cervical intraepithelial neoplasia, grades 2-4 (CIN2+) 
events, which are precursors to cervical cancer.  
The CDC grants the Tennessee Department of Health (TDH) funding for the EIP, who 
then in turn, sub-contracts Vanderbilt University Medical Center to conduct a portion of the 
work. Along with the four main components of the EIP, Tennessee is also one of the five sites to 
participate in the HPV IMPACT project. During my field experience, I had the opportunity to 
work both at Vanderbilt and TDH; my preceptors at each site were Dr. William Schaffner and 
Dr. Tim Jones, respectively. My primary appointment was through the EIP at Vanderbilt; 
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however, I did have the opportunity to participate in events at the Communicable and 
Environmental Diseases and Emergency Preparedness (CEDEP) department at TDH.  
 Emerging Infections Program- Vanderbilt 
The Tennessee Emerging Infections Program at Vanderbilt houses three main programs: Active 
Bacterial Core Surveillance, Flu-Surv NET, and the HPV-IMPACT Project. Portions of other 
programs such as HAIC, FoodNet, TickNet, and other special projects are also conducted onsite. 
Through my field experience, I was able to either shadow or work in each of these main 
programs. 
 
 Active Bacterial Core Surveillance 
 Database Audit 
The Active Bacterial Core Surveillance team collects surveillance data on invasive 
pathogens such as Neisseria meningitidis, Streptococcus pneumoniae, Group A and B 
Streptococcus, Listeria monocytogenes, and Haemophilus influenzae. To collect these data, the 
surveillance officers build relationships with hospitals and infection preventionists, collect 
reports from public health and private labs, and utilize state databases and registries. Up until 
2015, the data were stored in an Access database, and as of 2016, the data will be entered into 
REDCap, which is a secure web application created by Vanderbilt for building and managing 
online surveys and databases (Harris et al., 2009). During my field experience, I had the 
opportunity to conduct a 10% random audit of the 2015 Access database. This project will be 
covered in Chapter 2.  
 Pneumococcal Carriage Study 
 
Within the ABCs there is an ongoing study focused on pneumococcal carriage in adults aged 
65 and older. In 2010, the Advisory Committee on Immunization Practices (ACIP) 
recommended that the 7-valent pneumococcal conjugate vaccine (PCV7) be replaced with the 
13-valent pneumococcal conjugate vaccine (PCV13) for children within the United States. This 
recommendation decreased rates of invasive pneumococcal disease for both children and adults 
(Centers for Disease Control, 2010); however, the rates in adults aged > 65 years were still high. 
 9 
Because of this, the ACIP recommended routine use PCV13 for adults within that age group 
(Tomczyk et al., 2014). This project, sponsored by the CDC, has three main objectives as listed 
below (Centers for Disease Control, Adult Pneumococcal Carriage Study,  2016): 
1. Define the prevalence and serotype distribution of S. pneumoniae in adults > 65 years 
prior to the widespread use of PCV-13 in this patient population. 
2. Assess risk factors for S. pneumoniae colonization.  
3. Provide baseline data to assess the impact of the new ACIP recommendation on carriage 
rates in the same patient population with later surveys.  
This is a cross-sectional study that involves nasopharyngeal and oropharyngeal swabs, which 
will be utilized to assess pneumococcal carriage. Four of 10 EIP sites participate in this study: 
Georgia, Tennessee, Maryland, and New York. My role within this project was to enroll patients 
prior to the nurse collecting a biological specimen. This included obtaining informed consent and 
filling out the health survey and other paperwork. 
 Late Onset Group B Strep 
My capstone project utilized group B Streptococcal data, which is housed within the 
ABCs group. Both the project and the ABCs will be explained further in Chapter 3.  
 
 Flu-Surv Net 
 The Flu Team at Vanderbilt collects data on laboratory confirmed hospitalized influenza 
cases during each annual flu season which goes from October 1
st
 to April 30
th 
of every year. The 
catchment area includes eight counties within middle Tennessee: (Cheatham, Davidson, 
Dickson, Sumner, Robertson, Rutherford, Williamson, and Wilson). This information is sent to 
the CDC where it is used in the Flu View weekly surveillance report. The Vanderbilt team also 
analyzes the data to assess problems such as the undetected burden of influenza hospitalization in 
children in Tennessee using a capture recapture method (Grijalva et al., 2007) and the 
socioeconomic disparities among influenza hospitalization in Tennessee (Sloan et al., 2015). 
During the second day of my field experience, I was able to attend a Flu Team site visit from the 
CDC. Through this, I gained a complete overview of the program, including an appreciation of 
its future directions. 
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The EIP team at Vanderbilt will be attending the Society of Clinical Research Associates 
annual meeting in October of 2016. I worked with two of the Flu team members to create a 
poster to present at this meeting. For this poster, I prepared the summary statistics and figures 
and wrote the abstract. To do this, I utilized 2015 seasonal influenza surveillance data. Figure 1.2 
is a representation of the poster to be presented in October.  
 
HPV Impact Project 
The HPV- Impact program uses population based surveillance to evaluate the impact of 
the HPV vaccination program and HPV vaccine efficacies. As one of the smaller EIP projects, 
the catchment area is limited to Davidson County, TN. Outcomes that are assessed include the 
enumeration of CIN 2+ cases within catchment area, evaluation of the HPV subtypes in CIN2+ 
lesions, and the assessment of how the change in screening recommendations impacts screening 
rates in different age populations. The HPV-Impact team acquires data through many different 
avenues. In Tennessee, CIN 2+ is a reportable disease, and information about cases are acquired 
through submitted pathology reports to the Tennessee Cancer Registry. Cases are also 
ascertained through relationships with pathologists, laboratories, and women’s clinics. For this 
project, I was involved in clinic site visits, during which I reviewed patient charts to complete 
case report forms.   
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 Conclusions 
 
My field experience at the Tennessee Emerging Infections Program provided me with the 
opportunity to experience many different aspects of public health. Participating in meetings at 
the Tennessee Department of Health allowed me to observe regional and state wide 
epidemiology and surveillance efforts. During this time, TN had an outbreak of measles, and I 
was able to see how state-level outbreak response takes place. Through the collection of case 
information for the ABCs and HPV-Impact, I learned what types of pertinent information need to 
be collected for disease monitoring and surveillance.  
In addition to surveillance and monitoring, I also learned about good clinical practice, 
Institutional Review Board (IRB) protocols, and clinical trials through the pneumococcal 
carriage study. With this, I was able to interact with the public while following strict HIPAA and 
IRB regulations.  
 12 
 
Chapter 2 - 2015 Active Bacterial Core Surveillance Database Audit 
 Introduction 
 
Under the current grant cycle, the CDC does not require EIP sites to perform database 
audits. However, with the new grant starting in 2017, each site within the EIP will be required to 
perform an annual audit of each of their databases. To prepare for these audits, the TN ABCs 
group wanted to construct a database that would house all of the audit data and could be merged 
with the current REDCap database. To meet this need, I created a database and performed a 
random 10% audit of the 2015 ABCs data to test the utility of the database model.  
 Objectives 
 
The objectives of this audit were to create a process by which future audits can be 
completed and to track discrepancies found between the hard copy of the case report form (CRF) 
and the electronic entry. The resulting report from the audit was used to assess the program’s 
data entry protocol and highlight areas that need revisions or reeducation.  
 Methods 
 Database 
 
REDCap is a secure web-based application created by Vanderbilt for building and 
managing online surveys and databases (Harris et al., 2009). In 2016, the TN ABCs program 
changed from using a Microsoft Access database to the REDCap platform. Because of this, I 
decided to create my audit database form within REDCap. This will allow my database to be 
merged with the main database after further optimizations. The entry form has a space to enter 
up to ten discrepancies between the hard copy and electronic CRF. Each error is categorized as 
either a data entry error or a data omission error. A data entry error is defined as an error in 
which an item is transferred to the electronic database incorrectly. Examples include spelling 
errors, incorrectly checked boxes, or correcting answers on the form without updating the 
database. There is a drop down menu to select which question the error was on and a section for 
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comments to explain what the discrepancies were.  In addition, each error has a field for the data 
manager to comment on whether the discrepancy was fixed, why/how, and the date of correction. 
Figure 2.1 shows an example of the database entry form. A copy of the ABCs main CRF form is 
in Appendix A. 
 
 
  
 Audit 
 
 A random 10% sample was pulled from the 2015 database using SAS 9.4; this resulted in 
a sample size of 129 case report forms. Cases were then audited and errors were marked and 
 
Figure 2.1 REDCap database entry page for the 2015 ABCs audit.  
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entered into the database. Once I completed this audit, I held a meeting with the lead 
Surveillance Officer and Database Manager to discuss the findings and how to move forward. 
 
 Results 
 Of the 129 cases audited, all of them had at least one error. Table 2.1 enumerates the 
errors for each CRF; as an example, 95 cases reviewed had four errors. Omitted errors were the 
most common with an average of 3.4 per CRF while 
data entry errors averaged 1.6 per CRF.  There were 
sections of the CRF that were routinely flagged as 
incorrect. Table 2.2 shows the sections that had the 
most common errors. These include middle initials 
being omitted from the electronic database, improper 
hospital codes being reported, improper reporting of 
symptoms, and surveillance officer name and date 
being excluded from the electronic copy. Of these 
errors, the submitted by and date fields were the ones 
with the most discrepancies at 62.8% and 65.9% of the 
CRFs containing the error, respectively. One of the 
most interesting discrepancies noted involved the 
pregnancy status; if the male gender was selected, the 
surveillance officers still filled out the questions 
regarding pregnancy. This became a problem when 
entering this into the database, because the database 
manager skipped over these questions which left a discrepancy between the two versions of the 
form. This was found on 31% of the CRFs.  
 
 
 
Table 2.1: Number and type of errors per case 
report form for the 2015 10% database audit.  
Number 
of Errors 
Performed 
Error Type Total 
CRFs with 
Error 
number 
Omitted 
Errors 
Entry 
Errors 
1 77 52 129 
2 53 61 114 
3 67 39 106 
4 69 26 95 
5 64 11 75 
6 45 8 53 
7 26 2 28 
8 15 2 17 
9 12 1 13 
10 8  8 
Total 436 202 660 
Average/ 
CRF 
3.379845 1.565891 5.12 
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 Discussion 
  During the meeting with the lead SO and data manager, we were able to propose plans 
for future data collection and entry. A major point of 
emphasis is reeducation for both SOs and the data entry 
managers on how to utilize hospital ID and lab ID codes. 
The audit showed that 57 (44%) of the forms had at least 
one of the hospital types coded incorrectly. To remedy this, 
the database analyst who created the hospital ID sheet will 
attend a future SO meeting and walk through how to 
correctly identify hospitals. Another needed area of 
restructuring is the standardization of questions answered. 
Not all SOs fill out every question, and not every question 
needs to be filled out. For instance, when checking off 
symptoms of infection, SOs are only supposed to choose 
bacteremia without focus if no other symptom applies. However, few officers still chose this 
option along with other symptoms. When this happened previously, the data manager would 
omit bacteremia and only enter the other symptoms. However, to increase the quality of the CFR, 
the sheet will now be sent back to the SO to be corrected through the proper channels. This 
increases the integrity of the data, and helps to reeducate the officers. Finally, there were certain 
areas such as the name of the surveillance officer and the date submitted for entry that were 
routinely answered but not entered into the database. The rationale behind this was that the CDC 
does not collect those fields. However, because the site is moving towards paperless data, 
frequent audits, and increasing in-house analyses, these fields are important and should be both 
filled out and entered.  
The database interface is easy to understand and use. Reports can be pulled by year, audit 
status, error type and question where the error was on, and more.  For future use, there should be 
a third choice for error type- Blank CRF Field. There are a few questions that surveillance 
officers leave blank when reporting, but are needed for CDC purposes. This information is 
entered by the data manager but not annotated onto the hard copy of the CRF. I found that this 
type of omission does not necessarily fit in the definition of an omitted error, and believe it 
Table 2.2 Common Errors found on 2015 
Active Bacterial Core surveillance Case 
Report Forms 
Field  Errors 
% of 
CRFs 
Patient Information 66 51.2 
Hospital ID 39 30.2 
Lab ID 26 20.2 
Treatment ID 40 31 
Pregnancy Status 40 31 
Symptoms 37 28.7 
Underlying 
Conditions 33 25.6 
Submitted By 81 62.8 
Date 85 65.9 
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would beneficial to create a category specifically for it. This problem arises because, per 
protocol, the data manager is not supposed to add or change any part of the case report form.  
 
 The 2015 database audit was a very insightful look into how data is cleaned and kept 
accurate. Through this process we were able to reach a consensus on important changes that can 
take place to increase the accuracy and precision of the ABCs data.  
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Chapter 3 -  Socioeconomic Disparities and Late Onset Group B 
Streptococcus in Tennessee, 2010-2014 
 Introduction 
 
Since its emergence in the 1970’s, Group B Streptococcus (GBS) has been the leading 
cause of neonatal sepsis. Streptococcus agalactiae is a gram-positive bacterium that inhabits the 
gastrointestinal tract of humans and has a secondary colonization site in the urogenital tract. GBS 
can cause invasive disease in infants, pregnant or post-partum women, and elderly adults, with 
the highest incidence of disease being in neonates younger than 3 months.  Within this neonatal 
age group there are two classifications of GBS disease, early onset (EO) and late onset (LO). 
Early onset, which is a result of vertical transmission, occurs in infants less than seven days old 
and late onset, which can be acquired from the mother or environmental sources, occurs between 
days seven and 89. Infant infection with primarily causes sepsis, pneumonia, and meningitis, but 
can also cause focal infection including osteomyelitis, septic arthritis, and cellulitis (Gibbs, 
Schrag, & Schuchat, 2004). Additionally, the development of meningitis can result in long-term 
neurologic sequelae.  
Risk factors for EO GBS have been well described (Gibbs et al., 2004) (Schuchat et al., 
1990). Factors that contribute to the development of neonatal disease encompass maternal 
colonization of GBS in the urogenital tract, prolonged rupture of membranes, preterm delivery, 
GBS bacteriuria during pregnancy, birth of a previous child with GBS disease, maternal 
chorioamnionitis, young maternal age, African American race, Hispanic ethnicity, and low levels 
of GBS antigen specific antibodies. Less is known about the risk factors of LO GBS disease. 
Currently, it is thought that male sex, black race, maternal colonization, having a twin with LO 
GBS, and extreme prematurity are associated with an increased risk of disease  (Le Doare & 
Heath, 2013).  
Studies have shown that intrapartum prophylaxis (IPP) with penicillin is the best method 
for preventing EO disease and maternal illness from GBS (Centers for Disease Control, 1996).  
In 1992, the American Academy of Pediatrics (AAP) and the American College of Obstetricians 
and Gynecologists (ACOG) each released documents on GBS prevention in newborns. The AAP 
recommended that women who tested positive for GBS through prenatal cultures at or after 37 
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weeks and exhibited one of the following signs be treated with IPP: rupture of membranes >12 
hours prior to delivery, preterm labor or membrane rupture (<37 weeks gestation), intrapartum 
fever (>99.5° F), a multiple gestation pregnancy, or had a previous delivery of an infant with 
GBS disease. The ACOG, however, supported a risk factor based approach in which all women 
with one or more risk factors would receive IPP. These factors included preterm labor (<37 
weeks gestation), premature rupture of membranes (<37 weeks gestation), prolonged rupture of 
membrane (>18 hours before delivery), previous child affected by symptomatic GBS infection, 
or maternal fever during labor. These two views were echoed in the CDC’s 1996 MMWR 
publication of “Prevention of Perinatal Group B Streptococcal Disease: A Public Health 
Perspective” and adhering to either guideline was acceptable (Centers for Disease Control， 
1996). The incidence prior to these guidelines (early 1990’s) was 1.7 per 1,000 live births for 
early onset GBS and approximately 0.4 per 1,000 live births for late onset GBS (Verani et al., 
2010). After implementation of the guidelines, the incidence rate of EO GBS had decreased by 
70% to 0.5 cases per 1,000 live births in 1999. However, the rate of LO remained stable (Schrag, 
Gorwitz, Fultz-Butts, & Schuchat, 2002).  
In 2002, the CDC released a revision to the 1996 guidelines. This major revision 
supported the move to a unified universal prenatal screening strategy in which all pregnant 
women would be screened for GBS colonization between 35 and 37 weeks of gestation, unless a 
woman presents with bacteriuria or had a previous infant with invasive GBS disease. Intrapartum 
prophylaxis was indicated in women who had a previous infant with invasive GBS disease, GBS 
bacteriuria during her current pregnancy, a positive GBS screening culture during the current 
pregnancy- unless a planned cesarean section was performed in the absence of labor and the 
rupture of membrane, unknown GBS status, and any of the following- delivery at <37 weeks 
gestation, amniotic membrane rupture >18 hours, or an intrapartum temperature of >100.4° F 
(Schrag et al., 2002). A woman would not be treated with IPP if she did not test positive for 
GBS, even if she exhibited other risk factors. After these guidelines were implemented, the 
incidence of EO dropped further to 0.34 – 0.37 cases per 1,000 live births and LO stayed level at 
0.32 cases per 1,000 live births (Berardi et al., 2013). Figure 3.1 shows how the incidence of 
early- and late- onset GBS changed from 1990-2008 in the Active Bacterial Core Surveillance 
areas.  
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The guidelines that are currently in place were published in 2010. Minor revisions took 
place in all of the following areas: identification of candidates for IPP, specimen collection and 
processing, antibiotic dosing, and newborn management. In 2014, the incidence of early onset 
GBS was estimated to be 0.24 cases per 1,000 live births (Centers for Disease & Prevention, 
2016). Again, the incidence for late onset has remained fairly stable.  
 
 
 
 With the proportion of late onset GBS cases increasing from approximately 25% of total 
neonatal GBS cases in 1990 to 50% today, it is important to elucidate the pathogenesis and 
source of infection for LO GBS. Because it is not transmitted vertically, IPP treatment has no 
effect on the rates of infection. Instead, it is pertinent to understand the risk factors of late onset 
GBS more fully so that improved education and policy can be implemented to decrease these 
 
Figure 3.1: Incidence of early- and late- onset GBS in the Active Bacterial Core 
Surveillance catchment area from 1990-2008. Image from Verani, et. al., 2010.  
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rates.  A prospective cohort study conducted from 2003-2010 found that preterm neonates had 
the highest rates of late onset GBS and the highest mortality. In addition, they found that most 
mothers carried GBS during the time of LO diagnosis and that IPP was associated with delayed 
presentation of symptoms (Berardi et al., 2013).  
  
We utilized 2010-2014 ABCs late onset group B Streptococcus data to analyze 
socioeconomic disparities within middle Tennessee cases from 2010-2014. Our analysis aims to 
explore the socioeconomic status of late onset GBS cases in hopes to guide future studies in 
identifying new risk factors. This work will also be presented at the Society of Clinical Research 
Associates annual conference in October 2016. 
  
 Objective 
The objective of this project was to evaluate data to assess risk factors for LO GBS. This is to 
serve as a pilot for a larger, more in depth study on the assessment of socioeconomic disparities 
and other risk factors associated with the development of late onset group B Strep infections in 
Tennessee and other EIP locations. This project will probe into risk factors for GBS to inform 
future policy and education.  
 
 
 
 Methods 
 Data Collection 
Data provided by the TN EIP was analyzed for socioeconomic trends. Group B Streptococcus 
data is collected along with data from other invasive pathogens as part of the Active Bacterial 
Core surveillance program. The surveillance area encompasses 20 urban counties within 
Tennessee, which totals 3.95 million people and includes 60% of the state’s population. Case 
ascertainment is active-, laboratory-, and population based. Surveillance officers (SO) receive 
reports on cases from hospital labs, diagnostic labs, and hospital infection prevention staff. Once 
received, the SO determines if the event meets the case definition as follows: isolation of GBS 
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from a normally sterile site in a resident of the surveillance catchment area. Normally sterile sites 
include, but are not limited to, blood, 
cerebrospinal fluid, pleural fluid, 
pericardial fluid, bone, joint fluid, and 
internal body sites (lymph node, brain, 
heart, liver, spleen, vitreous fluid, kidney, 
pancreas, ovary, or vascular tissue). SOs 
collect pertinent medical information on 
confirmed cases through medical report 
review and completion of a standardized 
case report form. For GBS cases, there is an 
additional form called the Neonatal 
Expanded Form, which collects data 
specifically pertaining to GBS risk factors. 
A copy of the CRF and Neonatal Expanded 
form located in Appendix A and Appendix 
B, respectively. Over the course of 2010-
2014, 111 cases of GBS in children aged 7-
89 days (late onset) were identified in the 
Tennessee surveillance area. To be included 
in the analysis, a case needed both the main 
CRF and an expanded neonatal form 
completed. Figure 3.2 illustrates the 
guidelines utilized to narrow 5 years of 
ABCs data down to the 111 cases utilized 
in these analyses. Throughout my field 
experience, I was able to shadow and assist SOs in the completion of CRFs in both Nashville and 
Knoxville; however, I was not able to collect information on a neonatal GBS case. 
 
 
 
2010-2014 ABCs Cases 
N=5,312 
ABCs Cases with GBS  
N=1,530 
Late Onset GBS 
N=112 
Cases with Matching 
Neonatal GBS forms, N=111 
Figure 3.2: Flow chart describing study 
inclusion criteria. Cases were first filtered by 
date range, then pathogen, age range, and 
whether the case had both the main CRF and 
Expanded Neonatal CRF completed.  
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 Data Analysis 
 
To obtain neighborhood level information, each case was geocoded according to the 
patient’s place of residence at the time of culture 
analysis. Using ArcGIS software, ArcMap, each case 
was assigned to a census tract. Census tract data were 
then merged with population  
information from the US Census Bureau’s American 
Community Survey (ACS). The ACS is an ongoing 
survey that provides annual information about the 
nation and communities; the data used in this study was 
aggregated over five years (2010-2014), and values for 
socioeconomic indicators were extracted for use. Of the 
111 LO GBS cases, 69 were successfully geocoded to 
the roof-top level, 38 were at street address level, and 
two were at street level. According to ArcGIS, street 
address level represents and interpolated location along 
a street given the house number within a house range 
and street name level uses only the street name with no 
house or group of houses pinpointed.  Two of the cases 
could only be geocoded to postal code level and were, 
therefore, excluded from neighborhood level rates.  
We calculated crude average annual incidence (IR) rates 
of LO GBS in Tennessee per 10,000 population during the 5-year period. This was done using 
yearly live birth data as a denominator for individual level characteristics (gender, race) and 
census tract population data of children less than five years of age for neighborhood level 
characteristics (population density, percent below poverty level, percent college educated, 
percent employed, and the percent of population with a female head of household). College 
educated was defined as someone who was 25 years and over that completed at least some 
college education, and a female head of household was defined as children/ population under the 
age of 18 years in households with a female head of household and no husband present. Age 
Table 3.1: Cases of Late Onset Group 
B Streptococcus by county from 2010- 
2014. 
2010-2014 Tennessee Case Counts 
County Cases Percentage 
of total Cases 
Anderson 1 0.90 
Blount 0 0.00 
Cheatham 2 1.80 
Davidson 21 18.92 
Dickson 1 0.90 
Grainger 0 0.00 
Hamilton 8 7.21 
Jefferson 3 2.70 
Knox 10 9.01 
Loudon 0 0.00 
Madison 4 3.60 
Roane 1 0.90 
Robertson 2 1.80 
Rutherford 5 4.50 
Seveir 1 0.90 
Shelby  45 40.54 
Sumner 3 2.70 
Union 0 0.00 
Williamson 4 3.60 
Wilson 0 0.00 
Total 111 100.00 
Table 3.1: Cases of Late Onset Group 
B Streptococcus by c unty from 2010- 
2014. 
2010-2014 Tennessee Case Counts 
County Cases Percentage 
of total Cases 
Anderson 1 0.90 
Blou t 0 0.0  
Cheatham 2 1.8  
Davidson 21 18.92 
Dickson 1 0.90 
Grainger 0 0.0  
Hamilton 8 7.21 
Jefferson 3 2.70 
Knox 10 9.01 
Loud n 0 0.00 
Madison 4 3.6  
Roane 1 0.90 
Robertson 2 1.8  
Rutherford 5 4.50 
Seveir 1 0.90 
Shelby  45 40.54 
Sumner 3 2.7  
Union 0 0.00 
Williamson 4 3.6  
Wilson 0 0.00 
Total 111 100.0  
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standardization was not possible due to the small age range designated for the disease (7-89 days 
old). We also calculated the rate ratio (RR) and rate difference (RD) for each variable. Rate ratio 
and rate difference are defined below. Rate ratio is defined as the incidence rate of disease in the 
exposed group divided by the incidence rate of disease in the unexposed, or reference, group, and 
the rate difference is defined as the incidence rate of disease in the exposed group less the 
incidence rate of disease in the reference group. Analyses were performed using SAS 9.4 and 
Excel.  
 
 Results 
From 2010 through 2014 there were 111 cases of LO GBS in the Tennessee surveillance 
area. Twenty-four of the cases occurred in 2010, 21 cases in 2011, 25 cases in 2013, and 22 cases 
in 2014. The overall crude incidence rate was 4.41 cases per 10,000 population. The number of 
cases per county in the catchment area is shown in Table 3.1. Shelby (Memphis) and Davidson 
(Nashville) Counties had the highest counts of LO GBS with 45 and 21, respectively. Frequency 
data showed that there is a proportionally high number of children with Medicaid assistance as 
opposed to private or other types of insurance. In addition, the data revealed that as the age of the 
mother increased, the number of GBS cases decreased. The mother’s age group that had the 
highest amount of cases was 16-20 with one-third of the cases. Figure 3.3 shows the breakdown 
of cases by insurance type, mother’s age at birth, gestational age at birth, birth weight, type of 
delivery, and whether the neonate was fed breast milk. Each of these variables have been 
proposed as risk factors for LO GBS. The risk factors presented in red are associated with lower 
socioeconomic status. 
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For individual level socioeconomic data, the incidence rates for both male and female 
neonates were similar at 4.34 (95% CI = 3.2-5.65) and 4.47 (95% CI = 3.73-5.31) per 10,000 
population, respectively. The incidence in black neonates (8.82 per 10,000 population, 95% CI = 
7.38-10.27) was higher than in white (2.45/10,000 population, 95% CI = 1.63-3.27). Table 3.2 
shows the individual and neighborhood level characteristics featured in this project. As shown 
within the table, incidence rates did not vary numerically within each neighborhood level 
variable. The lowest incidence of disease was found in areas with >700 people per square mile 
(urban demographic) with 4.76 cases per 10,000 population (95% CI = 0.7-8.82), and the highest 
was found in areas with 200-699 people per square mile (suburban) with an incidence of 7.15 
cases per population (95% CI = 5.21-9.09). For people living below poverty the incidence rates 
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ranged from 5.99 per 10,000 population (95% CI = 3.82- 8.15) in areas where 10.0-19.9 percent 
of people lived below poverty level to 6.96 per 10,000 population (95% CI = 6.28-7.64) in areas 
where >20 percent of the population lived below poverty level. The rate ratio for the two 
categories of percent of population employed was 0.85 (95% CI = 0.57-1.27). The higher of the 
two rates occurred in the category where <50% of people were employed with 6.93 cases per 
10,000 population (95% CI = 6.52-7.33), and the lower rate was 5.88 per 10,000 population 
(95% CI = 3.18-8.58) where 50-65.9% of the population was employed. This would support the 
idea that living in a population with a higher percentage of people employed would be protective 
against LO GBS. For percent of population with a female head of household, the highest rate 
ratio was 1.17 (95% CI (0.57-1.88). The reference for this was <20 percent of the population 
with female heads of household and the comparison was with census tracts that had 20-39.9% 
female heads of household. While the vast majority of cases belong to a category where greater 
than 40% of the population received a college education, the incidence was actually the lowest 
with 6.33 (95% CI = 5.63-7.04) per 10,000 per population. This is in comparison to 7.63 (95% 
CI = 0-16.8) and 7.43 (95% CI = 4.93-9.73) per 10,000 population for 15-24.9 percent and 25-
39.9 percent receiving a college education, respectively.   
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Discussion 
Despite prevention efforts, late onset group B Streptococcal incidence rates have 
remained stable since the 1970’s when it, along with early onset GBS, emerged as the leading 
cause of neonatal sepsis. Consequently, with the decrease in EO GBS incidence rate, the 
proportion of late onset to early onset cases has risen. Therefore, it is important to elucidate the 
risk factors of LO GBS to lower the incidence rate. Having a better understanding of the risk 
factors for this disease will help to increase education and better inform policy which can work 
Table 3.2: Average annual incidence rates, relative rates, and rate differences of late onset group B 
Streptococcus in Tennessee from 2010-2014. 
Characteristic 
Cases, 
no.(%) Incidence* 95%CI 
Rate 
Ratio 95% CI 
Rate 
Diff.  95%CI 
Individual-level 
Data 
Total 
N=111 
 
  
 
  
 
  
Sex 
        
 
M 56 (50.45) 4.34 (3.2-5.65) Ref 
 
Ref 
 
 
F 55 (49.55) 4.47 (3.73-5.31) 1.03 (0.71-1.49) 0.13 (-1.23-1.36) 
Race 
        
 
White 42 (37.8) 2.45 (1.63-3.27) Ref 
 
Ref 
 
 
Black 63 (57.8) 8.82 (7.38-10.27) 3.64 (2.47-5.38) 6.37 (4.71-8.03) 
 
Other 6 (5.4) 6.58 (2.5-10.67) 2.69 (1.14-6.28) 4.13 (-.05-8.31) 
         Neighborhood-Level 
Data 
Total 
N=109 
 
  
 
  
 
  
% Below Poverty 
       
 
<5.0 12 (11.01) 6.21 (1.79-10.64) Ref 
 
Ref 
 
 
5.0-9.9 20 (18.35) 6.44 (3.80-9.08) 1.04 (0.51-2.12) 0.23 (-4.92-5.39) 
 
10.0-19.9 22 (20.18) 5.99 (3.82-8.15) 0.96 (0.48-1.94) -0.22 (-4.89-4.47) 
 
>20 55 (50.46) 6.96 (6.28-7.64) 1.12 (0.77-1.63) 0.75 (-4.17-5.67) 
% College Educated 
       
 
15.0-24.9 2 (1.83) 7.63 (0-16.8) Ref 
 
Ref 
 
 
25.0-39.9 25 (22.94) 7.34 (4.93-9.74) 0.96 (0.23-4.05) -0.29 (-9.77-9.19) 
 
>40 82 (75.23) 6.33 (5.63-7.04) 0.83 (0.56-1.33) -1.3 (-10.50-7.90) 
%Employed  
       
 
<50 75(68.8) 6.93 (6.52-7.33) Ref 
 
Ref 
 
 
50.0-65.9 34(31.2) 5.88 (3.18-8.58) 0.85 (0.57-1.27) -1.05 (-3.78-1.68) 
 
>66 0 (0) - - - 
 
- 
 %Female HH 
       
 
<20.0 21 (19.23) 5.96 (3.57-8.36) Ref 
 
Ref 
 
 
20.0-39.9 34 (31.19) 6.95 (4.09-9.81) 1.17 (0.68-2.00) 0.99 (-2.74-4.72) 
 
40.0-59.9 22 (20.18) 6.31 (4.72-7.9) 1.06 (0.57-1.88) 0.35 (-2.52-3.23) 
 
>60.0 32 (29.36) 6.91 (6.06-7.75) 1.16 (0.67-2.00) 0.95 (-1.59-3.49) 
Population Density 
       
 
0-<200 39 (35.78) 6.848 (5.09-8.60) Ref 
 
Ref 
 
 
200-699 54 (49.54) 7.149 (5.21-9.09) 1.04 (0.69-1.57) 0.301 (-2.31-2.92) 
 
>700 16 (14.68) 4.76 (0.7-8.82) 0.70 (0.29-1.24) -2.088 (-6.51-2.33) 
*per 10,000 population 
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to lower the incidence. This project was a preliminary step to a larger data analyses to address 
this problem.  
We chose the abbreviated time period of 2010-2014 for three reasons. First, the CDC 
guidelines changed in 2010 and we did not want to compare across guidelines. Another change 
that happened in 2010 was an increase in surveillance population for the ABCs. We started this 
project intending to use 2015 data, but unfortunately, the Tennessee Department of Health had to 
delay the release of live birth data from the beginning of May to the beginning of August.  
To help decide what risk factors to study, case counts and frequency data were assessed 
for different characteristics. From this, we found that there was a higher proportion of black 
neonates, young mothers, and Medicaid recipients with LO GBS in our sample. This indicated 
that lower socioeconomic status could be a risk factor for the development of LO GBS. One of 
the few known risk factors for LO GBS is being of black race. This was confirmed in our study 
with the IR in black neonates being 3.64 (95% CI = 2.47-5.38) times higher than in white 
neonates.  
One interesting phenomenon in our data is that 82 (75%) of the cases occurred in a 
population where greater than 40% of the population is college educated; yet 75 (68.8%) of the 
cases resided in an area where less than 50% are employed. While minute, an increasing trend in 
incidence rates is demonstrated as the percent of population living below poverty increases. The 
rate ratio of >20% of the population compared to the reference of <5.0% is 1.12 (95% CI = 0.77-
1.63). This indicates that high poverty has 1.12 times higher rate of LO GBS than low poverty.  
Because of the small sample size, a risk factor analysis was not carried out within this 
project. Instead, we chose to focus on descriptive statistics. Another limitation of this study is 
that the variables were assessed independently and their relationship was not taken into account.  
With a low average national incidence level of 0.28 cases per 1,000 live births, I would 
recommend conducting a retrospective case-control study in the future (Centers for Disease 
Control, 2014). To gain enough power, the study should utilize data from all 10 EIP sites starting 
from 2010. For the control population, the EIP has access to outpatient data, and I would match 
on age, time, and county and set a ratio of four controls per one LO GBS case. The controls 
would be selected based on illnesses that do not include infections, possibly acute conditions like 
gastrointestinal upset. Because the study would be based off of secondary data, I would probe 
into the same readily available factors that were investigated in this study with the addition of 
 28 
insurance type (Medicaid, private, other). To analyze the data, I would utilize a logistic 
regression, compare odds ratios and test for statistical significance between baseline and models 
that incorporate our measures of socioeconomic disparities  
 
 Currently, there is very limited knowledge regarding risk factors of LO GBS. The aim of 
our study was to analyze Tennessee’s data in hopes to elucidate socioeconomic disparities within 
LO GBS cases. However, this analysis provided an insight into the limitations of the small 
number of Tennessee’s cases, and, instead, can serve as a pilot for a larger, EIP wide study of LO 
GBS.   
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Chapter 4 - Conclusion 
My field experience at the Tennessee Emerging Infections Program gave me a great 
insight into how population surveillance is conducted. During this experience, I learned many 
difference facets of collection, management, and maintenance of databases. On my first day with 
the program, I was able to attend an annual CDC Flu team site visit, which provided me an 
extensive introduction, not only to Flu-Surv, but also to all sections of the program. It was very 
interesting to see how much of a collaborative spirit there is in the CDC/EIP site relationship. In 
addition to a federal level perspective, I was also able to shadow at the state level and attend 
surveillance meetings with state and local public health agents. Towards the end of my field 
experience, my role changed from listening in meetings to leading them. For both of my projects 
and the Flu-Surv poster, I was leading small group meetings to discuss progress and future 
directions. 
The database audit project taught me how to create a functional database. I also learned 
how to conduct quality control of datasets, which is extremely important for obtaining clean and 
accurate data. However, I believe the most important revelation to me during the database audit 
was that each of the numbers shown in a table corresponds to real a person. I spent many hours 
exploring case report forms, and I was shaken up every time I read about a person not surviving 
an infection. Prior to this, it was very easy to overlook the fact that these data points are people 
who have experienced one of these diseases. 
My LO GBS work primarily functioned to set the EIP site up for larger future. This 
enabled us to visualize the raw data and what types of questions could be answered from it. 
Through this project, I learned how to clean and present summarized data for reports, work in 
SAS 9.4, and apply measures such as incidence rates. The TN EIP site plans to propose a study 
utilizing data from all 10 sites. Future studies on the risk factors for this disease will hopefully 
guide policy and provide education that can lead to a decrease in the incidence of LO GBS. 
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Appendix 
Appendix A: Active Bacterial Core Surveillance Sample Case Report Form 
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Appendix B: Expanded Neonatal Surveillance form 
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